The Journal of Bone and Joint Surgery (American). 2006;88:1208-1214.
doi:10.2106/JBJS.E.00007
© 2006 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the activities for this article:
 CME 2: April, May, June 2006 (publication date July 5, 2006; expiration dat...
Foot/Ankle Test 8: Summer 2006 (publication date August 15, 2006; expiratio...
Adult Knee Reconstruction Test 12: Summer 2006 (publication date August 15,...
Right arrow Letters to the Editor: Submit a response
Right arrow Letters to the Editor: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mecikoglu, M.
Right arrow Articles by Esemenli, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mecikoglu, M.
Right arrow Articles by Esemenli, T.
Related Collections
Right arrow Adult Hip
Right arrow Adult Knee
Right arrow Foot/Ankle
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?

The Effect of Proteolytic Enzyme Serratiopeptidase in the Treatment of Experimental Implant-Related Infection

Mete Mecikoglu, MD1, Baransel Saygi, MD1, Yakup Yildirim, MD2, Evrim Karadag-Saygi, MD3, Saime Sezgin Ramadan, MD3 and Tanil Esemenli, MD3

1 Department of Orthopaedic Surgery, PTT Hospital, E-5 ûzeru Bostanci 34000, Istanbul, Turkey. E-mail address for B. Saygi: baranselsaygi{at}superonline.com
2 Department of Orthopaedic Surgery, Acibadem Hospital, Kadikóy 34010, Istanbul, Turkey
3 Departments of Physical Medicine and Rehabilitation (E.K.-S.), Pathology (S.S.R.), and Orthopaedics (T.E.), Marmara University Hospital, Tophanelioglu Cad 34100 Altunizade, Istanbul, Turkey

Investigation performed at the Animal Research Laboratory, Marmara University School of Medicine, Istanbul, Turkey

The authors did not receive grants or outside funding in support of their research for or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

Background: Infection around an implanted orthopaedic device is a devastating complication, and the treatment of infections involving slime-forming bacteria is especially difficult. The purpose of the present study was to evaluate the effectiveness of a proteolytic enzyme, serratiopeptidase, in the eradication of a periprosthetic infection in an in vivo animal model.

Methods: In sixty Sprague-Dawley rats, the medullary canal of the right femur was drilled through the intercondylar notch and was inoculated with a Staphylococcus epidermidis strain (ATCC 35984) with a high slime-producing capacity. The cavity was filled with polymethylmethacrylate cement, and a Kirschner wire that had contact with the knee joint was inserted. None of the animals received any treatment for two weeks. Twenty rats were killed at two weeks after the inoculation in order to determine if the infection had become established. The remaining forty rats were randomized into two groups. One group received serratiopeptidase enzyme injections into the knee joint in addition to antibiotic therapy for four weeks, and the other group received intra-articular saline solution injections together with the same antibiotic therapy. The animals from both groups were killed two weeks after the end of therapy (on Day 56). The knee specimens were evaluated bacteriologically and histologically to determine the prevalence of persistent infection and the effects of the enzyme on local tissue.

Results: At two weeks, inoculated bacteria grew on culture of specimens from twelve (63.2%) of nineteen animals in the no-treatment group. Microbiological testing suggested that infection persisted in only one (5.6%) of eighteen animals in the serratiopeptidase-and-antibiotic group, whereas it was present in six (37.5%) of sixteen animals in the antibiotic-only group (p = 0.001). Histological evaluation showed similar results (kappa = 0.92).

Conclusions: Serratiopeptidase was effective for eradicating infection caused by biofilm-forming bacteria in this experimental animal model. The antibiofilm property of the enzyme may enhance antibiotic efficacy in the treatment of staphylococcal infections.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


Letters to the Editor:

Read all Letters to the Editor

Availability of Serratiopeptidase
Professor Laura Selan, et al.
JBJS Online, 14 Nov 2006 [Full text]
Dr. Saygi et al. Respond to Professor Selan and Dr. Artini
Baransel Saygi, M.D., et al.
JBJS Online, 14 Nov 2006 [Full text]